RecruitingNCT07727083
Blood
T-cell large granular lymphocyte leukemia
14
studies recruiting now
as of 7 Sept 2026
139
studies registered in total
as of 7 Sept 2026
10
countries with a recruiting site
as of 7 Sept 2026
27 Jul 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT01137825
Registry of Older Patients With Cancer
RecruitingPhase 1 / Phase 2NCT05475925
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
RecruitingNCT05978141
A Registry for People With T-cell Lymphoma
RecruitingPhase 1NCT05010005
A Study of Ruxolitinib and Duvelisib in People With Lymphoma
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 14 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new T-cell large granular lymphocyte leukemia study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About T-cell large granular lymphocyte leukemia
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (STAT3).
Treatments being studied
7 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 2Ruxolitinib (Jakavi)
Phase 2Fludarabine
Phase 2Alemtuzumab (Campath mabcampath)
Phase 2Tipifarnib
Phase 1/2Azacitidine (Azacitidine)
Phase 1/2Ulviprubart
Phase 1Humik-Beta-1
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).